RANDOMIZED CONTROLLED TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR THE TREATMENT OF CHRONIC HEPATITIS C
- 29 February 2000
- Vol. 12 (2) , 165-170
- https://doi.org/10.1006/cyto.1999.0530
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- MODULATION BY BIOLOGIC RESPONSE MODIFIERS OF HEPATITIS C VIRUS ANTIGEN-INDEPENDENT CYTOKINE SECRETION IN BLOOD MONONUCLEAR CELLSCytokine, 1999
- Natural history of hepatitis CHepatology, 1997
- A Comparative Review of Colony-Stimulating FactorsDrugs, 1997
- GM-CSF and its effects on replication of HIV-1 in cells of macrophage lineageJournal of Leukocyte Biology, 1997
- The Treatment of Chronic Viral HepatitisNew England Journal of Medicine, 1997
- Granulocyte-macrophage colony-stimulating factor as adjuvant therapy for interferon α treatment of chronic hepatitis cCytokine, 1996
- Volunteer Blood Donors with Antibody to Hepatitis C Virus: Clinical, Biochemical, Virologic, and Histologic FeaturesAnnals of Internal Medicine, 1995
- Cytokine therapeutics: lessons from interferonalpha.Proceedings of the National Academy of Sciences, 1994
- Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis BHepatology, 1993
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1992